Abcam and Genedata Collaborate to Accelerate AI-Driven Antibody Development at Global Scale

Summary

Abcam and Genedata announced a partnership to combine their capabilities in antibody development and enterprise data platforms to accelerate AI-driven innovation. The collaboration aims to enhance data connectivity and deliver high-quality reagents to researchers faster at global scale.